Ursus americanus (American black bear): 123784520
Help
Entry
123784520 CDS
T07931
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
uar
Ursus americanus (American black bear)
Pathway
uar01524
Platinum drug resistance
uar04010
MAPK signaling pathway
uar04115
p53 signaling pathway
uar04148
Efferocytosis
uar04210
Apoptosis
uar04215
Apoptosis - multiple species
uar04623
Cytosolic DNA-sensing pathway
uar04650
Natural killer cell mediated cytotoxicity
uar04657
IL-17 signaling pathway
uar04668
TNF signaling pathway
uar04726
Serotonergic synapse
uar04932
Non-alcoholic fatty liver disease
uar04933
AGE-RAGE signaling pathway in diabetic complications
uar04936
Alcoholic liver disease
uar05010
Alzheimer disease
uar05012
Parkinson disease
uar05014
Amyotrophic lateral sclerosis
uar05016
Huntington disease
uar05020
Prion disease
uar05022
Pathways of neurodegeneration - multiple diseases
uar05132
Salmonella infection
uar05133
Pertussis
uar05134
Legionellosis
uar05145
Toxoplasmosis
uar05146
Amoebiasis
uar05152
Tuberculosis
uar05160
Hepatitis C
uar05161
Hepatitis B
uar05162
Measles
uar05163
Human cytomegalovirus infection
uar05164
Influenza A
uar05165
Human papillomavirus infection
uar05167
Kaposi sarcoma-associated herpesvirus infection
uar05168
Herpes simplex virus 1 infection
uar05169
Epstein-Barr virus infection
uar05170
Human immunodeficiency virus 1 infection
uar05200
Pathways in cancer
uar05203
Viral carcinogenesis
uar05205
Proteoglycans in cancer
uar05206
MicroRNAs in cancer
uar05210
Colorectal cancer
uar05222
Small cell lung cancer
uar05416
Viral myocarditis
uar05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
uar00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
123784520 (CASP3)
04668 TNF signaling pathway
123784520 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
123784520 (CASP3)
09143 Cell growth and death
04210 Apoptosis
123784520 (CASP3)
04215 Apoptosis - multiple species
123784520 (CASP3)
04115 p53 signaling pathway
123784520 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
123784520 (CASP3)
04650 Natural killer cell mediated cytotoxicity
123784520 (CASP3)
04657 IL-17 signaling pathway
123784520 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
123784520 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
123784520 (CASP3)
05206 MicroRNAs in cancer
123784520 (CASP3)
05205 Proteoglycans in cancer
123784520 (CASP3)
05203 Viral carcinogenesis
123784520 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
123784520 (CASP3)
05222 Small cell lung cancer
123784520 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
123784520 (CASP3)
05161 Hepatitis B
123784520 (CASP3)
05160 Hepatitis C
123784520 (CASP3)
05164 Influenza A
123784520 (CASP3)
05162 Measles
123784520 (CASP3)
05168 Herpes simplex virus 1 infection
123784520 (CASP3)
05163 Human cytomegalovirus infection
123784520 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
123784520 (CASP3)
05169 Epstein-Barr virus infection
123784520 (CASP3)
05165 Human papillomavirus infection
123784520 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
123784520 (CASP3)
05133 Pertussis
123784520 (CASP3)
05134 Legionellosis
123784520 (CASP3)
05152 Tuberculosis
123784520 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
123784520 (CASP3)
05145 Toxoplasmosis
123784520 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
123784520 (CASP3)
05012 Parkinson disease
123784520 (CASP3)
05014 Amyotrophic lateral sclerosis
123784520 (CASP3)
05016 Huntington disease
123784520 (CASP3)
05020 Prion disease
123784520 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
123784520 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
123784520 (CASP3)
05416 Viral myocarditis
123784520 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
123784520 (CASP3)
04932 Non-alcoholic fatty liver disease
123784520 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
123784520 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
123784520 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
uar01002
]
123784520 (CASP3)
Enzymes [BR:
uar01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
123784520 (CASP3)
Peptidases and inhibitors [BR:
uar01002
]
Cysteine peptidases
Family C14: caspase family
123784520 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
123784520
NCBI-ProteinID:
XP_045641776
LinkDB
All DBs
Position
Unknown
AA seq
277 aa
AA seq
DB search
MENTEHTVDAKAIKNSETKILHGSKSVDSGMSLDNSYKMDYPEMGLCIIINNKNFHRSTG
MTARSGTDVDAANLRETFTNLKYEVRNKNDLTREEILELMDSVSKEDHSKRSSFVCVLLS
HGDEGIIFGTNGPVDLKKLTGFFRGDYCRSLTGKPKLFIIQACRGTELDCGIETDSGAED
DMACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCTMLKLYAHKLEFMHILTRVN
RKVATEFESFSLDSAFHGKKQIPCIVSMLTKELYLYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaacaccgaacacacagtggatgcaaaagccattaaaaattcagaaacaaagatc
ttacatgggagcaaatcagtggactctggaatgtccttggacaacagttataaaatggat
tatcctgaaatgggtttatgtataataattaataataagaactttcatagaagtactgga
atgaccgctcggtctggtacagatgtagatgcagcaaacctccgggaaacattcacgaac
ttgaagtatgaagtcaggaataaaaatgatctcacacgcgaagaaattttggaattaatg
gacagtgtctctaaagaagatcatagcaaaaggagcagttttgtttgtgtgcttctaagc
catggggatgaaggaataatttttggaacaaatggacctgttgacctgaaaaaattaaca
ggtttcttcagaggggattactgtcgaagtctgactggaaaacccaaacttttcattatt
caggcctgccgaggcacagaactggactgcggtattgagacggacagcggagcagaggac
gacatggcctgtcagaaaataccagttgaagcggacttcttgtatgcctattctacagcc
cctggttactactcatggcgaaattcgaaggacggatcctggttcatccagtcactttgt
acgatgctgaaactgtatgctcacaagcttgagtttatgcacattcttacccgggttaac
cggaaggtagccacagaatttgagtccttctctcttgactctgcttttcatggaaagaaa
cagattccgtgtattgtgtcgatgctcacaaaagaactgtatctttatcactaa
DBGET
integrated database retrieval system